The association between asthma and atrial fibrillation: systematic review and meta-analysis

• Published in: Scientific reports Vol. 14; no. 1; pp. 2241 - 8
• Main Authors: Nogueira-Garcia, Beatriz, Alves, Mariana, Pinto, Fausto J., Caldeira, Daniel
• Format: Journal Article
• Language: English
• Published: London Springer Nature 26-01-2024; Nature Publishing Group UK; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308; 692/4019; 692/499; Asthma; Asthma - complications; Asthma - epidemiology; Atrial Fibrillation - complications; Atrial Fibrillation - epidemiology; Cardiac arrhythmia; Case-Control Studies; Clinical trials; Fibrillation; Heterogeneity; Humanities and Social Sciences; Humans; Longitudinal studies; Meta-analysis; multidisciplinary; Observational studies; Respiratory diseases; Risk assessment; Science; Science (multidisciplinary); Systematic review
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-50466-w

© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Respiratory disease and atrial fibrillation (AF) frequent coexist, but the risk of AF among asthma patients is less characterized. Growing evidence suggest that AF shares with asthma a systemic inflammation background and asthma treatments, such as beta agonists, have been associated with increased risk of cardiac arrhythmias. The aim of this systematic review was to assess the risk of AF in patients with asthma in observational studies. We search for longitudinal studies reporting AF outcome in asthma and control patients through MEDLINE, Cochrane Central Register of Controlled Trials and EMBASE. Pooled estimates of odds ratios (ORs) and 95% confidence intervals (CIs) were derived by random effects meta-analysis. Heterogeneity was assessed using the I2 test. The risk of bias of individual studies was evaluated using the ROBINS-E tool. The study protocol was registered at PROSPERO: CRD42020215707. Seven cohort/nested case–control studies with 1 405 508 individuals were included. The mean follow-up time was 9 years, ranging from 1 to 15 years. Asthma was associated with a higher risk of AF (OR 1.15. 95% CI 1.01–1.29). High heterogeneity (I2 = 81%) and overall “serious” risk of bias, lead to a very low confidence in in this result. Asthma was associated with an increased risk of AF. However, the high risk of bias and high heterogeneity reduces the robustness of these results, calling for further high-quality data.
This work was supported by national funds, Fundação para a Ciência e a Tecnologia, reference number UIDB/00306/2020.